Generation of Maternal Obesity Models in Studies of Developmental Programming in Rodents
Paul D Taylor1, Phillippa A Matthews2, Imran Y Khan2
1Division of Women's Health, Women's Health Academic Centre, King's College London and King's Health Partners, London, UK. Paul.taylor@kcl.ac.uk.
Insights
Maternal obesity during pregnancy, indicated by pre-pregnancy body mass index (BMI) and gestational weight gain (GWG), is linked to offspring cardio-metabolic risks. Rodent models show early life exposure to maternal obesity can lead to hypertension and metabolic syndrome in offspring.
Area of Science:
- Reproductive biology and developmental origins of health and disease (DOHaD).
- Metabolic and cardiovascular health research.
Background:
- Human cohort studies link pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) to offspring cardio-metabolic risk factors, including blood pressure.
- Rodent models demonstrate that maternal obesity during pregnancy can induce metabolic syndrome and hypertension in offspring, persisting from early development.
- These findings suggest that the in-utero environment of maternal obesity may predispose humans to early-onset metabolic syndrome and essential hypertension.
Purpose of the Study:
- To review the development and utility of rodent models for studying maternal overnutrition and obesity.
- To explore how these models generate hypotheses for clinical translation regarding offspring metabolic health.
- To inform the development of interventions targeting obesity-related comorbidities in future generations.
Main Methods:
- Development and characterization of rodent models simulating maternal overnutrition and obesity during gestation.
- Assessment of offspring cardio-metabolic parameters, including blood pressure and metabolic syndrome markers.
- Analysis of developmental programming related to the maternal nutritional environment.
Main Results:
- Rodent models successfully replicate key aspects of metabolic syndrome and hypertension observed in offspring of obese mothers.
- Early life exposure to maternal obesity in these models leads to persistent sympathetic hyperresponsiveness and elevated blood pressure.
- These models provide a platform for investigating the mechanisms linking maternal obesity to offspring metabolic dysfunction.
Conclusions:
- Rodent models of maternal obesity are crucial for understanding the developmental origins of metabolic syndrome and hypertension.
- Insights from animal studies support the hypothesis that maternal nutritional status during pregnancy impacts offspring long-term health.
- Further research using these models can guide interventions to mitigate the intergenerational effects of obesity and its comorbidities.
Abstract:
Mother-child cohort studies have established that both pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) are independently associated with cardio-metabolic risk factors in juvenile and adult offspring, including systolic and diastolic blood pressure. In rodent studies maternal obesity confers many facets of the metabolic syndrome including a persistent sympathy-excitatory hyperresponsiveness and hypertension acquired in the early stages of development. Insight from these animal models raises the possibility that early life exposure to the nutritional and hormonal environment of obesity in pregnancy in humans may lead to early onset of metabolic syndrome and/or essential hypertension. This chapter will address the development of rodent models of maternal overnutrition and obesity, which have proved invaluable in generating testable hypotheses for clinical translation and the development of intervention strategies to stem the swelling tide of obesity and its comorbidities predicted for future generations.
Related Concept Videos
Obesity
Introduction to Developmental Psychology
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Drug Dosing: Obese Patients
Typical Model Studies
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution


